Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Iloprost by PHAIT for Lung Cancer: Likelihood of Approval
Iloprost is under clinical development by PHAIT and currently in Phase III for Lung Cancer. According to GlobalData, Phase III...